Quantitative T1 brain mapping in early relapsing-remitting multiple sclerosis: longitudinal changes, lesion heterogeneity and disability
James G. Harper(University of Edinburgh), Michael J. Thrippleton(MRC Centre for Regenerative Medicine), Adam Waldman(Royal Society of Edinburgh), Rozanna Meijboom(MRC Centre for Regenerative Medicine), Siddharthan Chandran(Edinburgh Royal Infirmary), Agniete Kampaite(University of Edinburgh), Elizabeth N. York(University of Edinburgh), Patrick K. A. Kearns(University of Edinburgh), María del C. Valdés Hernández(MRC Centre for Reproductive Health)
Cited by 15
Related Papers
Neuroimaging standards for research into small vessel disease—advances since 2013
|The Lancet Neurology|2023|962
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial
|The Lancet Neurology|2008|774
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
|The Lancet Oncology|2011|649